MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 229 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q4 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $862 | -92.9% | 86,107 | -91.2% | 0.00% | -100.0% |
| Q2 2023 | $12,130 | -11.2% | 975,770 | +0.1% | 0.00% | 0.0% |
| Q1 2023 | $13,657 | -1.7% | 974,740 | +0.4% | 0.00% | 0.0% |
| Q4 2022 | $13,888 | -100.0% | 970,525 | -25.3% | 0.00% | -60.0% |
| Q3 2022 | $33,174,000 | -29.1% | 1,299,365 | -21.1% | 0.01% | -16.7% |
| Q2 2022 | $46,809,000 | -35.2% | 1,647,627 | -19.6% | 0.01% | -14.3% |
| Q1 2022 | $72,267,000 | -11.4% | 2,048,957 | +5.3% | 0.01% | 0.0% |
| Q4 2021 | $81,568,000 | +8.7% | 1,946,736 | +27.4% | 0.01% | 0.0% |
| Q3 2021 | $75,020,000 | +110.9% | 1,528,533 | +79.3% | 0.01% | +133.3% |
| Q2 2021 | $35,578,000 | +198.3% | 852,582 | +154.7% | 0.00% | +200.0% |
| Q1 2021 | $11,928,000 | – | 334,689 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $764,690,000 | 24.22% |
| Nekton Capital Ltd. | 1,111,102 | $39,189,000 | 9.66% |
| Pavadi Capital LLC | 133,279 | $4,701,000 | 4.14% |
| Curi Wealth Management, LLC | 420,446 | $14,829,000 | 2.57% |
| Select Equity Group, L.P. | 19,100,056 | $673,659,000 | 2.18% |
| Ownership Capital B.V. | 4,205,521 | $148,329,000 | 1.96% |
| Beck Bode, LLC | 167,969 | $5,924,000 | 1.34% |
| Parkman Healthcare Partners LLC | 77,389 | $2,730,000 | 0.80% |
| STONE RUN CAPITAL, LLC | 55,285 | $1,960,000 | 0.72% |
| Champlain Investment Partners, LLC | 3,582,530 | $126,356,000 | 0.65% |